Brainowl’s ‘Free’ IQ Test
“Free” offer could prove costly.
Bellyard Partners, LLC et al. v. Falfurrias Capital Partners, LP and Global Plasma Solutions, Inc.
24-cv-4128, N.D. Ga.
(Sept. 2024)
Products with Needlepoint Bipolar Ionization technology, including GPS-FC48-AC, GPS-FC24-AC, and others
Falsely representing that products eliminate the COVID-19 virus and produce cleaner air
Falsely representing that claims are based on independent testing when the company paid for the testing and the products do not achieve the same results in real world conditions
Pending
“Free” offer could prove costly.
Company’s animal welfare claims – and brand name – face increasing scrutiny.
Consumers balk at hidden junk fees.
TINA.org uncovers the limits of this carrier’s “unlimited” data plans.
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.